慢性淋巴细胞白血病中的NOTCH1突变与细胞周期G1/S转换增强及特定细胞周期蛋白过表达相关:靶向抑制的临床前依据
在378例经二代测序注释的慢性淋巴细胞白血病(CLL)病例中,NOTCH1突变(NOTCH1MUT)细胞的G0-G1期细胞周期组分呈现独特转录组谱,早期效应分子CCND3、CDK4和CDK6分别过表达38倍、27倍和9倍,且与更多细胞进入细胞周期相关。体外靶向抑制NOTCH1γ-分泌酶和CDK4/6可逆转细胞周期各时相分布并增强对NOTCH1MUT CLL细胞的杀伤,提示新的治疗途径。
要点
- NOTCH1MUT CLL细胞CCND3、CDK4、CDK6分别过表达38倍、27倍和9倍
- NOTCH1MUT细胞G0-G1期转录组谱与更多细胞进入细胞周期相关
- 体外抑制NOTCH1γ-分泌酶和CDK4/6可逆转细胞周期分布并增强杀伤
核心结论
- NOTCH1MUT CLL细胞具有独特的G0-G1期细胞周期组分转录组谱,早期效应分子过表达,且更多细胞进入细胞周期。
- 体外靶向抑制NOTCH1γ-分泌酶和CDK4/6可逆转细胞周期各时相分布并增强对NOTCH1MUT CLL细胞的杀伤,提示新的治疗途径。
研究设计与样本
- 在378例经二代测序注释的CLL病例中,对NOTCH1MUT细胞的细胞周期进行综合再评估,并进行体外靶向抑制实验。
主要发现
- NOTCH1MUT细胞显示独特的G0-G1期细胞周期组分转录组谱,早期效应分子过表达,复合体组分CCND3、CDK4和CDK6分别增加38倍、27倍和9倍。
- NOTCH1MUT细胞的该谱与更多细胞通过细胞周期相关。
- 体外靶向抑制NOTCH1γ-分泌酶和CDK4/6可逆转细胞周期各时相分布并增强对NOTCH1MUT CLL细胞的杀伤。
关键数值与推荐
- 在378例经二代测序注释的CLL病例中,NOTCH1MUT细胞CCND3、CDK4和CDK6分别增加38倍、27倍和9倍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Studies prior to next-generation sequencing (NGS) showed that the frequent indolent course of chronic lymphocytic leukaemia (CLL) is related to most cells remaining quiescent in the G0 -G1 cell cycle phase, due to the expression of dysregulated cyclin genes. Of note, the activating nature of the NOTCH1 mutation in T lymphoblastic leukaemia also drives the dysregulation of cell cycle genes. Our goal was to comprehensively revisit the cell cycle in NOTCH1-mutated CLL (NOTCH1MUT ) to test for potential therapeutic targets. Among 378 NGS-annotated CLL cases, NOTCH1MUT cells displayed a unique transcriptome profile of G0 -G1 cell cycle components, with an overexpression of early-phase effectors, reaching a 38-, 27- and ninefold change increase for the complex elements CCND3, CDK4 and CDK6, respectively. This NOTCH1MUT cells' profile was related to more cells traversing through the cell cycle. In-vitro targeted inhibition of NOTCH1 gamma-secretase and CDK4/6 reversed the distribution of cells through the cycle phases and enhanced the killing of NOTCH1MUT CLL cells, suggesting new therapeutic approaches.
引用
- Carrillo-Tornel S, Chen-Liang TH, Zurdo M, et al. NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition. Br J Haematol. 2022. PMID: 36573331. doi:10.1111/bjh.18609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。